arrow
M

Manfredi Rizzo

ras al khaimah medical and health sciences university
H指数:73
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of Glucoerb® and Epavin® on Cardiometabolic Profile in Adults with Overweight or Obesity: A Three-Month Real-World Study

格鲁科伯®和埃帕文®对超重或肥胖成人代谢心血管特征的影响:一项为期三个月的真实世界研究

2026-09-240
OA
Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes

通过益生元、益生菌、合生元和后生元靶向肠道-骨骼轴:从机制可行性到临床骨骼结局

2026-09-110
OA
Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer

肿瘤代谢:在癌基因信号、表观遗传学和免疫学交叉点上的新兴癌症治疗策略

2026-07-170
OA
Repurposing GLP-1 receptor agonists and SGLT-2 inhibitors in neurodegeneration and metabolically at-risk populations: Myth or reality? An overview of randomized clinical trials

GLP-1受体激动剂和SGLT-2抑制剂在神经退行性疾病及代谢高风险人群中的再利用:是神话还是现实?随机临床试验概述

2026-05-270
PRE
Natural supplements in breast cancer therapy: translational evidence; clinical safety; and emerging challenges

天然补充剂在乳腺癌治疗中的应用:转化医学证据;临床安全性;及新兴挑战

2026-04-300
OAAI
COVID-19 vaccination remains essential for healthcare professionals: clinical evidence from a Polish cross-sectional study

COVID-19疫苗接种对医疗专业人员仍至关重要:来自波兰横断面研究的临床证据

2026-04-160
OAAI
Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting—Expert Group Recommendations from Kuwait

CKM综合征的现代管理:GLP-1受体激动剂在多学科环境中的使用——科威特专家小组建议

2026-02-120
OAAI
Vitamin D supplementation and selected metabolic parameters in patients with type 2 diabetes and obesity: a prospective observational study

维生素D补充剂及选定代谢参数在2型糖尿病和肥胖患者中的研究:一项前瞻性观察性研究

2026-01-150
OAAI